tibco spotfire® platform (TIBCO)
Structured Review
Tibco Spotfire® Platform, supplied by TIBCO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spotfire+platform/tibco+spotfire+platform/pm32557294-2-2-2
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: ACS National Meeting - Exposition Article Snippet: Our products include the industry leading ChemDraw® application, Electronic Lab Notebooks (cloud based Elements and E-Notebook), & the Article Title: Development and Implementation of the AVAILS+ Collaborative Forecasting Tool for Production Assurance in the Kuwait Oil Company, North Kuwait (KOC NK) Article Snippet: AVAILSþ is a short-term forecasting tool designed to lead the production-assurance efforts of the North Kuwait Asset [Sabriyah, Raudhatain, Ratqa, Abdali, and Bahrah fields of the Kuwait Oil Company (KOC)].. The term “AVAILS” is a shorthand term for “Available Production,” whereas the “þ” connotes the extended capabilities of both the technology (suite of dashboard metrics) and the methodology (team building and collaboration).. The tool has been developed jointly between KOC North Kuwait (KOC NK) and Quantum Reservoir Impact (QRI). Article Title: A new genotype of hepatitis A virus causing transient liver enzyme elevations in Mauritius-origin laboratory-housed Macaca fascicularis . Article Snippet: Hepatitis A virus (HAV) infects humans and nonhuman primates, typically causing an acute self-limited illness.. Three HAV genotypes have been described so far for humans, and three genotypes have been described for nonhuman primates.. We observed transiently elevated liver enzymes in Mauritius-origin laboratory-housed macaques in Germany and were not able to demonstrate an etiology including HAV by serology and polymerase chain reaction (PCR). Article Title: Use of "Big Data" to Evaluate Responses to Changes in Regulatory Guidelines: Trends in Genotoxicity Testing Packages for New Pharmaceutical Products. Article Snippet: Background In 2006, a concept paper (ICH S2(R1)) describing the need for revision of the ICH guidelines on genotoxicity testing for new “small molecule” pharmaceuticals (then ICH S2A and ICH S2B) was finalised.. As a result, testing strategy has changed, and flexibility has been introduced in the form of two “equally suitable” options for completing the battery of genotoxicity studies required to support clinical development and marketing of new products.. Methods The TIBCO Spotfire platform was used to create a specific view of available in-house data on genotoxicity studies conducted to support pharmaceutical product development over a period of approximately 12 years. |

